InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Sjogren Eric, Vice-Président Senior, Découverte de Médicaments. Officer active across 1 companies, notably Calithera Biosciences, Inc.. In total, 8 disclosures have been published. The latest transaction was filed on 21 January 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
€2,0834,794 shares@ €0.434485.49% mcap8.2% of flow
Common Stock
SEC:0000899243-22-003135:0·
€2,0834,794 shares@ €0.434485.49% mcap16.5% of flow
Common Stock
SEC:0000899243-22-003135·
€10,56318,077 shares@ €0.584383.5% of flow
Common Stock
SEC:0000899243-22-001299·
€10,56318,077 shares@ €0.584341.8% of flow
Common Stock
SEC:0000899243-22-001299:0·
030,000 shares0
Common Stock
SEC:0000899243-21-043688·
030,000 shares0
Common Stock
SEC:0000899243-21-043688:0·
090,000 shares0
Common Stock
SEC:0000899243-21-042073·
090,000 shares0
Common Stock
SEC:0000899243-21-042073:0·
8 of 8 declarations
About Sjogren Eric
Eric Sjogren is Senior Vice President, Drug Discovery at Calithera Biosciences, Inc. He oversees research and development initiatives, contributing to innovation and the creation of new treatments in the biopharmaceutical sector.
